Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Core Scientific, Inc./tx Director's Dealing 2024

Mar 19, 2024

30992_dirs_2024-03-18_c75df04a-984b-42e2-bf62-85a0d64db0aa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Core Scientific, Inc./tx (CORZ)
CIK: 0001839341
Period of Report: 2024-03-15

Reporting Person: Rozov Yadin (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-15 Common Stock P 80000 $3.0746 Acquired 80000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-15 Tranche 2 Warrants $0.01 P 90000 Acquired 2029-01-23 Common Stock (90000) Direct

Footnotes

F1: The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $2.99 to $3.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within such range.

F2: Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments.

F3: The price reported is a weighted average price. These Tranche 2 Warrants were purchased in multiple transactions at prices ranging from $1.97 to $2.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants purchased at each separate price within such range.